Transcriptomics

Dataset Information

22

Expression data from A2780 (cisplatin-sensitive) and Round5 A2780 (cisplatin-resistant) cell lines.


ABSTRACT: Cisplatin and carboplatin are the primary first-line therapies for the treatment of ovarian cancer. However, resistance to these platinum-based drugs occurs in the large majority of initially responsive tumors, subsequently resulting in a poor long-term prognosis. To model the onset of drug resistance, we measured gene expression alterations associated with cisplatin resistance. We treated clonally derived, drug-sensitive A2780 epithelial ovarian cancer cells with increasing concentrations of cisplatin. After 5 cycles of drug selection, the isogenic drug-sensitive (parental A2780) and -resistant (Round5 A2780) cell lines were subjected to mRNA expression microarray analyses.

ORGANISM(S): Homo sapiens  

SUBMITTER: Kenneth P Nephew   Meng Li 

PROVIDER: E-GEOD-15372 | ArrayExpress | 2009-04-17

SECONDARY ACCESSION(S): GSE15372PRJNA123257

REPOSITORIES: GEO, ArrayExpress

altmetric image

Publications

Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer.

Li Meng M   Balch Curt C   Montgomery John S JS   Jeong Mikyoung M   Chung Jae Hoon JH   Yan Pearlly P   Huang Tim H M TH   Kim Sun S   Nephew Kenneth P KP  

BMC medical genomics 20090608


Cisplatin and carboplatin are the primary first-line therapies for the treatment of ovarian cancer. However, resistance to these platinum-based drugs occurs in the large majority of initially responsive tumors, resulting in fully chemoresistant, fatal disease. Although the precise mechanism(s) underlying the development of platinum resistance in late-stage ovarian cancer patients currently remains unknown, CpG-island (CGI) methylation, a phenomenon strongly associated with aberrant gene silencin  ...[more]

Similar Datasets

| GSE15372 | GEO
2010-06-19 | E-GEOD-15373 | ArrayExpress
2009-04-17 | GSE15373 | GEO
2009-04-17 | E-GEOD-15709 | ArrayExpress
2013-10-01 | E-MTAB-1858 | ArrayExpress
| GSE122287 | GEO
2016-01-15 | E-MTAB-3645 | ArrayExpress
2015-07-14 | E-MTAB-3645 | ExpressionAtlas
2016-07-06 | PXD001176 | Pride
2013-10-25 | E-GEOD-51683 | ArrayExpress